Peptide vaccination with tumor-associated antigens (mixed with Montanide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Peptide vaccination with tumor-associated antigens (mixed with Montanide), covering 2016-01-26 to 2016-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors [Phase 1]